Retracted: Measures of Adiposity and Risk of Testing Positive for SARS-CoV-2 in the UK Biobank Study

Retracted: Measures of Adiposity and Risk of Testing Positive for SARS-CoV-2 in the UK Biobank Study

Saved in:

Bibliographic Details
Main Author:	Journal of Obesity
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Journal of Obesity
Online Access:	http://dx.doi.org/10.1155/2022/9848453
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Baseline cardiometabolic profiles and SARS-CoV-2 infection in the UK Biobank.
by: Ryan J Scalsky, et al.
Published: (2021-01-01)

Impact of self-reported SARS-CoV-2 antibody positivity on cardiac structure and function: findings from UK Biobank CMR cohort
by: Chang Liu, et al.
Published: (2025-02-01)

Modelling optimal vaccination strategy for SARS-CoV-2 in the UK.
by: Sam Moore, et al.
Published: (2021-05-01)

Reliability of multi-site UK Biobank MRI brain phenotypes for the assessment of neuropsychiatric complications of SARS-CoV-2 infection: The COVID-CNS travelling heads study.
by: Eugene Duff, et al.
Published: (2022-01-01)

COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.
by: David A Wohl, et al.
Published: (2021-01-01)

The Dynamics of SARS-CoV-2 (RT-PCR) Testing
by: Nicole Joyce, et al.
Published: (2021-01-01)

Oocyte Retrieval in Asymptomatic Patients Positive for SARS-CoV-2
by: Allison Akers, et al.
Published: (2022-01-01)

A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
by: Kwang Su Kim, et al.
Published: (2021-03-01)

Reliability and validity of the UK Biobank cognitive tests.
by: Chloe Fawns-Ritchie, et al.
Published: (2020-01-01)

Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing.
by: Ithan D Peltan, et al.
Published: (2021-01-01)

Cost Effectiveness of Sample Pooling to Test for SARS-CoV-2
by: Baha Abdalhamid, et al.
Published: (2020-10-01)

SARS-CoV2 in public spaces in West London, UK during COVID-19 pandemic
by: Prashant Kumar, et al.
Published: (2023-07-01)

Testing behaviour and positivity for SARS-CoV-2 infection: insights from web-based participatory surveillance in the Netherlands
by: Jacco Wallinga, et al.
Published: (2021-12-01)

Pseudoneutralizing test for preclinical studies of vaccines against SARS-CoV-2
by: B. S. Cherepovich, et al.
Published: (2024-04-01)

Validation of the Diabetomics CovAB SARS-CoV-2 antibody test in children: comparison with serology
by: Manisha Gurumurthy, et al.
Published: (2024-11-01)

Delayed RT-PCR Time-To-Positivity in an adult with SARS-CoV-2 Infection
by: Nur Chandra Bunawan, et al.
Published: (2021-07-01)

Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.
by: Yin Mo, et al.
Published: (2021-10-01)

Deep learning and genome-wide association meta-analyses of bone marrow adiposity in the UK Biobank
by: Wei Xu, et al.
Published: (2025-01-01)

Adiposity, Metabolomic and Proteomic Signatures, and Liver Health: A Prospective Cohort Study in the UK Biobank
by: Longgang Zhao, et al.
Published: (2025-05-01)

The Intersection of SARS-CoV-2 and Diabetes
by: Jacob H. Nichols, et al.
Published: (2025-06-01)

In-silico Immunomodelling of SARS-CoV-2
by: Amirhosein Maali, et al.
Published: (2021-06-01)

SARS-CoV-2 associated encephalitis
by: Jasmina Poluga, et al.
Published: (2025-05-01)

Stability of SARS-CoV-2 phylogenies.
by: Yatish Turakhia, et al.
Published: (2020-11-01)

Susceptibility of rabbits to SARS-CoV-2
by: Anna Z. Mykytyn, et al.
Published: (2021-01-01)

SARS-CoV-2-Neutralizing Antibodies
by: Yawen Liu, et al.
Published: (2024-11-01)

Diagnostic accuracy evaluation of a point-of-care antigen test for SARS-CoV-2 and influenza in UK primary care (RAPTOR-C19)
by: Thomas R. Fanshawe, et al.
Published: (2025-01-01)

Diagnostic accuracy evaluation of a point-of-care antigen test for SARS-CoV-2 and influenza in UK primary care (RAPTOR-C19).
by: Thomas R Fanshawe, et al.
Published: (2025-01-01)

SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India.
by: Mansi Patel, et al.
Published: (2025-03-01)

Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic
by: Nishi Dave, et al.
Published: (2025-08-01)

Evaluation of the MAScIR SARS-CoV-2 M Kit 2.0 on the SARS-CoV-2 Infection
by: Amal Zouaki, et al.
Published: (2023-01-01)

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.
by: Felicitas Ruiz, et al.
Published: (2024-10-01)

At-Home Testing to Characterize SARS-CoV-2 Seroprevalence Among Children and Adolescents
by: Amina Ahmed, et al.
Published: (2025-05-01)

Cellulose-Based Colorimetric Test Strips for SARS-CoV-2 Antibody Detection
by: Mariana P. Sousa, et al.
Published: (2025-06-01)

Retracted: Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins
by: Bioinorganic Chemistry and Applications
Published: (2023-01-01)

Modelling the impact of the tier system on SARS-CoV-2 transmission in the UK between the first and second national lockdowns
by: Pantelis Samartsidis, et al.
Published: (2021-04-01)

Coxsackievirus A6 U.K. Genetic and Clinical Epidemiology Pre- and Post-SARS-CoV-2 Emergence
by: Alice M. Joyce, et al.
Published: (2024-11-01)

A study of anti-SARS-CoV-2 antibody positivity in Duhok City, Iraq
by: Nawfal R Hussein, et al.
Published: (2023-07-01)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
by: Abdullah G. Al-Sehemi, et al.
Published: (2022-05-01)

Co-infection associated with SARS-CoV-2 and their management
by: Vivek P Chavda, et al.
Published: (2022-10-01)

Prevalence of Viral and Bacterial Co-Infections in SARS-CoV-2-Positive Individuals in Cyprus 2020–2022
by: George Krashias, et al.
Published: (2025-05-01)